chr20-63659291-A-T
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001283009.2(RTEL1):c.-112A>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
RTEL1
NM_001283009.2 5_prime_UTR
NM_001283009.2 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.102
Publications
0 publications found
Genes affected
RTEL1 (HGNC:15888): (regulator of telomere elongation helicase 1) This gene encodes a DNA helicase which functions in the stability, protection and elongation of telomeres and interacts with proteins in the shelterin complex known to protect telomeres during DNA replication. Mutations in this gene have been associated with dyskeratosis congenita and Hoyerall-Hreidarsson syndrome. Read-through transcription of this gene into the neighboring downstream gene, which encodes tumor necrosis factor receptor superfamily, member 6b, generates a non-coding transcript. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2013]
RTEL1-TNFRSF6B (HGNC:44095): (RTEL1-TNFRSF6B readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring RTEL1 (regulator of telomere elongation helicase 1) and TNFRSF6B (tumor necrosis factor receptor superfamily, member 6b, decoy) genes on chromosome 20. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is unlikely to produce a protein product. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RTEL1 | ENST00000360203.11 | c.-112A>T | 5_prime_UTR_variant | Exon 2 of 35 | 5 | NM_001283009.2 | ENSP00000353332.5 | |||
RTEL1 | ENST00000508582.7 | c.-112A>T | 5_prime_UTR_variant | Exon 2 of 35 | 2 | ENSP00000424307.2 | ||||
RTEL1 | ENST00000370018.7 | c.-112A>T | 5_prime_UTR_variant | Exon 2 of 35 | 1 | ENSP00000359035.3 | ||||
RTEL1-TNFRSF6B | ENST00000492259.6 | n.-112A>T | upstream_gene_variant | 5 | ENSP00000457428.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 578256Hom.: 0 Cov.: 6 AF XY: 0.00 AC XY: 0AN XY: 310178
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
578256
Hom.:
Cov.:
6
AF XY:
AC XY:
0
AN XY:
310178
African (AFR)
AF:
AC:
0
AN:
16506
American (AMR)
AF:
AC:
0
AN:
34952
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
19294
East Asian (EAS)
AF:
AC:
0
AN:
33020
South Asian (SAS)
AF:
AC:
0
AN:
61944
European-Finnish (FIN)
AF:
AC:
0
AN:
46508
Middle Eastern (MID)
AF:
AC:
0
AN:
2534
European-Non Finnish (NFE)
AF:
AC:
0
AN:
332434
Other (OTH)
AF:
AC:
0
AN:
31064
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.